Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	24.98B -7.9%
Revenue (ttm)	164.16B +7.0%
Net Income	2.02B -31.3%
EPS	0.39 -32.5%
Shares Out	4.99B
PE Ratio	12.80
Forward PE	11.28
Dividend	0.20 (4.00%)
Ex-Dividend Date	Jun 8, 2026

Volume	30,611,093
Open	5.00
Previous Close	5.00
Day's Range	4.91 - 5.03
52-Week Range	4.48 - 5.84
Beta	0.19
Analysts	Buy
Price Target	5.86 (+16.97%)
Earnings Date	Aug 25, 2026

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 29,862
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2025, SHA:600998's revenue was 161.39 billion, an increase of 6.31% compared to the previous year's 151.81 billion. Earnings were 2.25 billion, a decrease of -10.07%.

Analyst Summary

According to 6 analysts, the average rating for 600998 stock is "Buy." The 12-month stock price target is ¥5.86, which is an increase of 16.97% from the latest price.

Price Target

¥5.86

(16.97% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error